Skip to main content
logo

Kerry Holford

Stock Analyst at Berenberg

(2.13)
# 2,917
Out of 5,058 analysts
10
Total ratings
42.86%
Success rate
10.38%
Average return
Main Sectors:
Healthcare
Top Industries:
Drug Manufacturers - General

Stocks Rated by Kerry Holford

Novo Nordisk
Sep 17, 2025
Upgrades: Buy
Price Target: n/a
Current: $49.00
Upside: -
Eli Lilly and Company
Sep 17, 2025
Downgrades: Hold
Price Target: $970 → $830
Current: $1,049.60
Upside: -20.92%